NeurAxis, Inc. (NRXS) Stock Ticker
Market factors today
Unlock the full NRXS picture
About NeurAxis, Inc.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
NRXS stock facts
| Ticker symbol | NRXS |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $94.3M |
| CEO | Brian Carrico |
| Employees | 24 |
| Headquarters | Carmel, IN, US |
| IPO date | 2023-08-09 |
| Website | neuraxis.com |
What you can see for NRXS on Tickr
Live NRXS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NRXS report.
Rankings
FAQ
What is the ticker symbol for NeurAxis, Inc.?
The ticker symbol for NeurAxis, Inc. is NRXS, listed on the New York Stock Exchange Arca.
What is NRXS?
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The…